Diclax

Quick links to important sections

Diclax

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diclax

What is Diclax?

Diclax is a medication belonging to a group of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs). It contains the active ingredient diclofenac, which is utilized for its properties in managing pain and reducing inflammation.

How it Works

The medication functions by inhibiting the production of prostaglandins, which are chemicals in the body that signal pain and contribute to swelling and inflammation at the site of injury or irritation. By reducing the concentration of these substances, Diclax helps to alleviate physical discomfort and decrease localized swelling.

Clinical Applications

Diclax is primarily used to address symptoms associated with various inflammatory conditions. It is commonly associated with the management of:

  • Joint and Bone Conditions: Including different forms of arthritis, such as osteoarthritis and rheumatoid arthritis.
  • Musculoskeletal Issues: Such as acute back pain, sprains, strains, and sports injuries.
  • Other Painful Inflammatory States: Including conditions like gout or discomfort following minor surgical procedures.

As an NSAID, the medication focuses on symptomatic relief by targeting the inflammatory response rather than treating the underlying cause of the condition.

What side effects are possible with Diclax?

Possible Side Effects and Safety Information: Diclax

Diclax (a non-steroidal anti-inflammatory drug or NSAID) carries Boxed Warnings from regulatory authorities regarding serious cardiovascular and gastrointestinal risks. Use should always be at the lowest effective dose for the shortest duration necessary to control symptoms.


Serious and Clinically Significant Adverse Reactions

  • Cardiovascular Thrombotic Events: Use of systemic Diclax is associated with an increased risk of serious, potentially fatal, cardiovascular thrombotic events, including myocardial infarction (MI) and stroke. This risk can increase with higher doses and longer duration of use. The drug is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.
  • Gastrointestinal Events: NSAIDs, including Diclax, cause an increased risk of serious gastrointestinal adverse events, such as bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. Elderly patients and those with a prior history of GI disease are at a higher risk.
  • Other Organ Toxicity: Serious reactions affecting the liver (hepatotoxicity), kidneys (renal toxicity, which may lead to new or worsening renal failure), and blood pressure (hypertension, fluid retention, and edema) have been documented.

Common Adverse Reactions

Commonly reported side effects primarily involve the gastrointestinal system, including nausea, indigestion (dyspepsia), diarrhea, constipation, and abdominal pain. Headaches and dizziness are also frequently reported.

Population-Specific Safety Considerations

  • Pregnancy: Diclax is contraindicated in women starting at 30 weeks gestation due to the risk of premature closure of the fetal ductus arteriosus.
  • Cardiovascular Disease: The drug is contraindicated in patients with established congestive heart failure (NYHA Class II-IV), ischemic heart disease, peripheral arterial disease, or cerebrovascular disease. Caution is required for patients with significant cardiovascular risk factors (e.g., hypertension, hyperlipidaemia, diabetes mellitus, smoking).

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Symptoms and Clinical Manifestations

An overdose of Diclax, defined as taking more than the recommended amount, may present with a spectrum of symptoms, ranging from mild to very severe. Common early signs include nausea, vomiting (which may sometimes contain blood), stomach pain, and diarrhea. Central nervous system effects such as dizziness, drowsiness, headache, and agitation may also occur.

In cases of very severe overdose, serious events have been documented, including seizures and coma. Other potential clinical manifestations involve organ systems, such as wheezing or trouble breathing, little or no urine output, high or low blood pressure, chest pain, and possible bleeding in the stomach and intestines. Patients with pre-existing conditions like asthma may be at a higher risk for exacerbated breathing problems.

Emergency Actions

Immediate medical attention is required for any suspected overdose. Contact a local emergency number or a certified poison control center right away. It is important to have the following information ready: the person's age, weight, and condition; the name of the product, including the strength; and the time and amount swallowed.

Treatment in an emergency setting will focus on supportive care and monitoring vital signs. Do not attempt to induce vomiting unless specifically instructed to do so by a healthcare professional or poison control, as this action may not be appropriate in all situations.

Therapeutic Uses of Diclax

Diclax may be part of symptomatic management, relevant across domains involving symptoms related to inflammatory or irritative states. It is generally considered relevant in clinical settings that involve acute or unstable symptom patterns.

The medication may assist with managing symptom clusters that may become intense or disruptive, such as the pain, stiffness, and swelling associated with chronic joint conditions like Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis. It provides support that helps ease the overall symptom burden, contributing to improved comfort during periods of heightened symptoms and assists with maintaining functional stability in situations where patients experience chronic joint discomfort. It is also used for managing symptoms associated with acute or episodic changes, such as physical discomfort from minor soft tissue injuries and manifestations like menstrual cramps and migraine headaches. Diclax is commonly used when short-term symptomatic assistance is appropriate, such as following minor surgical procedures. This supports general well-being during symptomatic phases and contributes to easing the overall symptom load during periods of localized discomfort.

Quick Fact: Relief for Inflammation and Pain

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The eligibility for using Diclax is strictly defined by official regulatory labeling, which outlines specific exclusions based on pre-existing health conditions and age. Most adults without contraindications are the primary eligible population.

Official Eligibility Status

Category Official Regulatory Classification
Populations for whom use is allowed (as stated in label): Adults (18 years and above). Adolescents (over 14 years) for certain forms [Source 1.1, 2.3].
Populations for whom use is contraindicated: Patients with severe heart failure (NYHA Class II-IV), established ischemic heart disease, or cerebrovascular disease [Source 1.3, 2.2]. History of allergic reactions to aspirin or other NSAIDs, active gastric or intestinal ulceration/bleeding, severe hepatic or renal failure, and CABG surgery [Source 1.2, 3.5, 4.2].
Age-related eligibility rules: Contraindicated in the last trimester of pregnancy (from 30 weeks gestation) [Source 1.2, 4.2]. Not recommended for children and adolescents under 14 years for standard oral doses [Source 2.3]. Older adults require caution [Source 1.2].
Eligibility-related restrictions: Caution is advised for patients with mild-to-moderate renal/hepatic impairment [Source 1.2]. Use in patients with significant cardiovascular risk factors is restricted to the lowest effective dose for the shortest duration after careful consideration [Source 1.5, 2.2].

These explicit eligibility restrictions, particularly the absolute contraindications related to severe organ dysfunction and cardiovascular history, govern who can be prescribed Diclax as documented in official government health information [Source 1.2, 2.2]. Women attempting to conceive should consider discontinuing the medicine as it may be associated with reversible infertility [Source 4.2].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information outlines specific drug-drug and drug-product interactions for Diclax (diclofenac) that may alter its safety or efficacy, or that of the co-administered agent.

Contraindicated and Non-Recommended Combinations

  • Coronary Artery Bypass Graft (CABG) Surgery: The medicine is strictly contraindicated for use in the setting of CABG surgery.
  • Other NSAIDs: Concomitant administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 selective agents and non-cardioprotective doses of Aspirin, is not generally recommended due to increased risk of serious gastrointestinal events.

Clinically Significant Interaction Categories

Interacting Product Category Official Constraint/Risk Monitoring Requirement
Anticoagulants/Antiplatelets (e.g., Warfarin) Increased risk of serious GI bleeding due to synergistic effect. Increased monitoring for signs of bleeding.
Antihypertensives (ACE Inhibitors, ARBs, Diuretics) Reduced efficacy of antihypertensive/natriuretic agents; risk of worsening renal function. Monitoring for blood pressure control and renal function, especially in high-risk patients.
Lithium / Methotrexate / Cyclosporine Increased plasma concentrations and potential for enhanced toxicity (e.g., lithium, methotrexate, cyclosporine nephrotoxicity). Strict monitoring for signs of drug-specific toxicity.
CYP2C9 Inhibitors (e.g., Voriconazole) Increased exposure of Diclax, potentially increasing adverse effects. Caution and monitoring required.

These interactions are categorized in official labeling to guide prescribing and management, focusing on minimizing toxicity and maintaining the therapeutic effectiveness of all co-administered agents.

Mechanism of Action

Modulation of Inflammatory Mediator Production

Diclax primarily works by inhibiting the cyclooxygenase (COX) enzymes . These enzymes are critical for converting arachidonic acid into prostaglandins, which are key mediators in the inflammatory response. This action modifies the early molecular steps in the eicosanoid synthesis pathway, altering the signaling events that contribute to local vascular changes and erythema.


Central and Peripheral Signaling Adjustment

The drug’s action affects physiological responses across the peripheral and central nervous systems. By reducing prostaglandin concentrations in the central nervous system, it resets the hypothalamic thermostat, which alters the thermal set point established by the hypothalamus. Simultaneously, its peripheral action reduces the sensitization of pain fibers, along with a supplementary mechanism involving the activation of ATP-sensitive potassium channels (KATP channels), which modifies the transmission of nociceptive signals.

Dosage and Administration Information

The administration of Diclax (Diclofenac) is based on established protocols, adhering to the principle of using the lowest effective dosage for the shortest duration possible. Its use is governed by the specific dosage form and the stated maximum daily dose.


Administration Routes and Dosing Rules

Administration Route Standard Dosing Regimens (Examples) Frequency & Maximums
Oral (Tablets) 50 mg to 75 mg per dose Divided daily dose (e.g., 2 to 3 times daily). Max dose is generally 150 mg/day (for Osteoarthritis) or up to 200 mg/day (for Rheumatoid Arthritis).
Oral (Solution) Single 50 mg packet Single dose for acute use. Safety and effectiveness of a second dose are not established.
Parenteral (IV/IM) 75 mg per dose Repeatable after 4 to 6 hours, not exceeding a total of 150 mg per day. Parenteral use is often limited to a maximum of two days.
Topical (Gel) Dose is measured by a dosing card (e.g., 2 g or 4 g) Typically applied 4 times daily. Total daily dose is restricted by formulation and treated area.

Procedural and Timing Instructions

Oral Tablets and Capsules:

  • Delayed/Extended-Release forms must be swallowed whole and must not be crushed, chewed, or broken.
  • Timing varies by form: Delayed-Release tablets are generally taken with or after meals, but specific forms, such as the oral solution and certain capsules, are taken on an empty stomach (e.g., 1 hour before or 2 hours after eating).

Preparation:

  • The oral solution powder must be mixed only with 1 to 2 ounces of plain water and consumed immediately; no other liquids should be used.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Diclax

The research evidence for Diclax (Diclofenac) is sourced from official regulatory reviews and studies published in peer-reviewed scientific literature. This overview describes the research scenarios and outcomes that have been observed, without providing clinical advice or making statements about how an individual might respond.


Evidence for Symptom Management in Osteoarthritis

Research has extensively explored Diclax for conditions marked by functional limitations such as Osteoarthritis (OA). Evidence is derived from short-term (6 to 12 weeks) randomized controlled trials (RCTs). Research explored whether oral and topical Diclax was associated with outcomes related to physical discomfort and daily functioning. Studies reported measurements of symptom severity in participants receiving Diclax that differed from the patterns observed in those receiving a placebo. The available RCT data provides limited insight into changes in function or pain status over periods exceeding one year.


Evidence for Chronic Inflammatory Joint Conditions

Diclax was studied in research exploring symptoms associated with chronic conditions like Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS). These trials often extended over intermediate periods (6 months to 1 year). Research examined changes in outcomes linked to inflammatory or irritative states. The evidence remains descriptive regarding the medicine’s effects on the structural course of these conditions, and research does not determine whether use of the medicine is associated with modifying the progression of joint damage.


Research on Acute, Episodic Pain Relief

The evidence base for acute pain is built on very short-duration, high-quality RCTs, often using models such as post-operative discomfort. Researchers monitored outcomes describing episodic or acute changes. The formulation of diclofenac potassium was associated with a more rapid onset of symptom change than other forms of the medicine in these models. Because these trials focus only on immediate effects, the follow-up durations were limited, and the results apply only to the specific conditions studied.


Understanding the Evidence Gaps and Uncertainties

Despite a volume of research, the evidence base contains limitations. The long-term effects are not fully established for many chronic use scenarios, as controlled trial follow-up durations were limited. Furthermore, while observational studies of real-world use are helpful, their non-randomized design means that certain findings regarding patient outcomes may only describe an association between Diclax use and an event, and not a direct cause.

Key Studies & References

  1. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial
  2. Indirect comparison of NSAIDs for ankylosing spondylitis: Network meta‑analysis of randomized, double‑blinded, controlled trials
  3. Diclofenac potassium restores objective and subjective measures of sleep quality in women with primary dysmenorrhea
  4. Diclofenac Linked to Higher Major Heart Risks Than Similar Drugs (Danish observational study)

Frequently Asked Questions (FAQ)

Common questions about Diclax (FAQ)

Q: What is the main difference between Diclax and other similar medications people talk about?

Diclax is categorized as a Nonsteroidal Anti-inflammatory Drug (NSAID), which is a classification shared by many pain and inflammation relievers. Official descriptions, based on its mechanism of action, classify Diclofenac as a non-selective inhibitor of the cyclooxygenase (COX) enzymes. This classification describes how it acts within the body.

Q: How quickly can I expect to feel the effect of Diclax after taking it?

The time frame for onset of effect can vary depending on the specific formulation. In studies of acute pain, such as migraine attacks, specific formulations like diclofenac potassium powder have been associated with pain relief starting as quickly as 15 minutes.

Q: Is Diclax considered a long-term or short-term treatment?

Official documents emphasize the use of the lowest effective dose for the shortest duration possible. Specific administration methods, like injection or certain specialized capsules, are explicitly recommended only for short-term treatment periods.

Q: Is it true that Diclax has been studied for conditions other than its main use?

Yes, the medicine has multiple officially recognized indications documented in regulatory materials. These list its use for conditions such as the signs and symptoms of osteoarthritis and rheumatoid arthritis. It is also indicated for the management of acute pain, including specific uses like migraine attacks and menstrual cramps.

Q: What are some less common but possible side effects of Diclax?

In addition to common gastrointestinal effects, official documentation lists other reported adverse reactions. These may include effects affecting the nervous system like drowsiness and confusion. Other documented side effects may involve dry mouth and unintentional weight changes.

Q: Can women who are planning to become pregnant use Diclax?

Official information notes that the use of diclofenac may be associated with reversible infertility because it can affect ovulation. Women who are planning to become pregnant, or who are having difficulties conceiving, are advised to consult their healthcare provider regarding discontinuation.

Q: Does Diclax need to be taken at a specific time of day?

Official instructions prioritize consistency and spacing of doses, rather than a specific time of day. For certain forms, official guidance focuses on maintaining consistent dosing intervals, such as 10 to 12 hours, between doses, rather than a specific clock time.

Q: Has Diclax been recalled or had any major warnings recently?

The medicine is accompanied by major safety information known as Boxed Warnings in regulatory documents. These warnings highlight the potential for serious events, including cardiovascular issues such as stroke and myocardial infarction (MI), and severe gastrointestinal risks like bleeding and ulceration.

Q: Is it safe to take over-the-counter pain relievers while on Diclax?

Official guidance advises against taking Diclax at the same time as other nonsteroidal anti-inflammatory drugs (NSAIDs). Because of the potential for complex drug interactions, it is important to discuss the use of any additional pain reliever or medication with a healthcare professional.

Q: Why is Diclax sometimes described as a 'selective or non-selective' medication?

In official pharmacological descriptions, Diclofenac is classified based on its mechanism of action. It is described as a non-selective inhibitor because it affects both the cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes.

Q: If I am taking an herbal product, could it interact with Diclax?

It is important to inform a healthcare provider of all products being taken, including herbal supplements and vitamins. This is necessary because these products may carry a potential risk of interaction with Diclax.

Q: Is Diclax the kind of drug that requires regular blood tests?

For patients taking Diclax over an extended period, regulatory documents recommend the monitoring of blood count. This standard practice applies to long-term use of Diclax, similar to other medicines in the Nonsteroidal Anti-inflammatory Drug (NSAID) class.

Q: Do I need a prescription to get Diclax?

Most oral forms of Diclofenac are generally classified as prescription-only medications by regulatory bodies. While certain low-strength topical forms may be available over-the-counter in some areas, the systemic oral products typically require a prescription.

Q: What happens if I miss a dose of Diclax?

If a dose is missed, official instructions typically advise that the patient skip the missed dose and resume their regular schedule. It is explicitly stated that a double dose should never be taken to compensate for the one they missed.

Q: Why does Diclax sometimes cause dry mouth?

Dry mouth is documented in official product information as a possible adverse experience associated with the use of Diclax. It is one of the less common side effects reported to regulatory bodies.

Q: Is it normal to feel a bit tired after taking Diclax?

Yes, official safety information documents that effects such as drowsiness and a general feeling of malaise or unusual tiredness are side effects associated with Diclofenac. These are reported effects on the nervous system.

Q: Can Diclax be taken by people who have diabetes?

Regulatory information notes that diabetes is considered a cardiovascular risk factor which is a factor noted for caution when using NSAIDs. Furthermore, official reports detail a major interaction risk involving lactic acidosis if Diclax is taken with the diabetes medication metformin.

Q: Does Diclax interact with alcohol? (Informational only)

Yes, regulatory information notes that consuming alcohol while taking Diclax can substantially increase the risk of stomach bleeding. Patients should discuss the use of alcohol with their healthcare provider.

Q: How long does Diclax stay in my system?

The amount of time Diclax stays in the system is described by its half-life, which is the time it takes for half of the drug to be eliminated from the plasma. For Diclofenac, the elimination half-life is documented to be approximately one to two hours.

Q: Can Diclax affect my ability to drive or operate machinery?

Yes, Diclax can cause side effects like dizziness and drowsiness that affect alertness. Official documents include warnings that patients should not drive or operate machinery until they are certain of how the medicine affects their concentration and physical state.

Q: Is there a generic version of Diclax available?

Yes, Diclofenac, the active ingredient in Diclax, is widely available as a generic medication. Regulatory and pharmacy sources confirm that a lower-cost generic version exists.

Q: Does Diclax cause weight gain or weight loss?

Official product information includes weight changes as a documented adverse experience that has been reported with the use of Diclofenac. This is listed under metabolic and nutritional disorders.

Q: What if I take Diclax with a daily vitamin or supplement?

Regulatory guidance highlights the importance of sharing a complete medical history, including the use of daily vitamins and supplements. This comprehensive disclosure is necessary due to the potential for interactions with Diclax.

Q: If Diclax causes a skin rash, is that a serious side effect?

While a skin rash can be a common and generally mild side effect, the official safety profile also documents the potential for severe, life-threatening skin reactions. These serious reactions include conditions like Stevens-Johnson syndrome and toxic epidermal necrolysis.

Q: Why do people sometimes say Diclax causes confusion?

Official safety documents list confusion as a reported adverse effect. This effect is documented in the product information under nervous system disorders associated with the use of Diclofenac.

Q: Are there different warnings for different countries regarding Diclax?

Yes, the required official labeling and warnings can vary depending on the regulatory authority. Bodies like the U.S. FDA and the European Medicines Agency (EMA) issue their own separate, country-specific prescribing information and safety warnings for the medicine.

How should Diclax be stored and disposed of?

How to Store and Dispose of Diclax?

Storage Conditions

Diclax (diclofenac) must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The medicine must be protected from moisture and kept in its original, tightly closed container.

It is mandatory to store the medicine out of the reach and sight of children and pets, and it should not be refrigerated or frozen. Unused medicine must be discarded after the labeled expiration date.

Disposal Instructions

Official guidelines recommend disposing of unused or expired Diclax through an authorized drug take-back program.

If a take-back program is not available, the medicine should be mixed with an unappealing substance (like dirt or used coffee grounds), placed in a sealed bag, and disposed of in the household trash. Do not flush this medicine down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Diclax found in:

A-Z Index: